About Harmony Biosciences
Harmony Biosciences is a company based in Plymouth Meeting (United States) founded in 2017.. Harmony Biosciences has raised $345 million across 6 funding rounds from investors including Fidelity Investments, Orbimed and HBM Healthcare Investments. The company has 268 employees as of December 31, 2024. Harmony Biosciences has completed 1 acquisition, including Zynerba Pharma. Harmony Biosciences offers products and services including ZYN002. Harmony Biosciences operates in a competitive market with competitors including QurAlis, Passage Bio, Evox Therapeutics, MindMed and Relmada, among others.
- Headquarter Plymouth Meeting, United States
- Employees 268 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Harmony Biosciences Holdings, Inc.
-
Annual Revenue
$714.73 M22.8as on Dec 31, 2024
-
Net Profit
$145.49 M12.91as on Dec 31, 2024
-
EBITDA
$214.94 M-0.67as on Dec 31, 2024
-
Total Equity Funding
$345 M (USD)
in 6 rounds
-
Latest Funding Round
$200 M (USD), Debt – Conventional
Jan 27, 2020
-
Investors
Fidelity Investments
& 9 more
-
Employee Count
268
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Harmony Biosciences
Harmony Biosciences is a publicly listed company on the NASDAQ with ticker symbol HRMY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Harmony Biosciences
Harmony Biosciences offers a comprehensive portfolio of products and services, including ZYN002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for Fragile X Syndrome in neurological patients
Unlock access to complete
Unlock access to complete
Leadership Team
31 people
Operations Team
9 people
Finance and Accounting
7 people
Software Development Team
6 people
Product Management Team
5 people
Legal and Compliance
5 people
Human Resources and Administration
4 people
Sales and Marketing
3 people
Unlock access to complete
Funding Insights of Harmony Biosciences
Harmony Biosciences has successfully raised a total of $345M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $200 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $200.0M
-
First Round
First Round
(22 Sep 2017)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Debt – Conventional - Harmony Biosciences | Valuation |
investors |
|
| Aug, 2019 | Amount | Series E - Harmony Biosciences | Valuation |
investors |
|
| Mar, 2019 | Amount | Debt – Conventional - Harmony Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Harmony Biosciences
Harmony Biosciences has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, Orbimed and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
CRG is recognized as a premier healthcare investment partner.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Harmony Biosciences
Harmony Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Zynerba Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Transdermal cannabinoid therapies are developed for neurological disorders.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Harmony Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Harmony Biosciences Comparisons
Competitors of Harmony Biosciences
Harmony Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QurAlis, Passage Bio, Evox Therapeutics, MindMed and Relmada, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs and CSF devices are developed for ALS treatment.
|
|
| domain | founded_year | HQ Location |
Gene therapies for CNS rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Exosome-based gene therapies for neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapies for brain health disorders are developed.
|
|
| domain | founded_year | HQ Location |
Novel drug products for chronic pain treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Harmony Biosciences
Frequently Asked Questions about Harmony Biosciences
When was Harmony Biosciences founded?
Harmony Biosciences was founded in 2017.
Where is Harmony Biosciences located?
Harmony Biosciences is headquartered in Plymouth Meeting, United States. It is registered at Plymouth Meeting, Pennsylvania, United States.
Is Harmony Biosciences a funded company?
Harmony Biosciences is a funded company, having raised a total of $345M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $200M, raised on Sep 22, 2017.
How many employees does Harmony Biosciences have?
As of Dec 31, 2024, the latest employee count at Harmony Biosciences is 268.
What is the annual revenue of Harmony Biosciences?
Annual revenue of Harmony Biosciences is $714.73M as on Dec 31, 2024.
What does Harmony Biosciences do?
Developer of therapeutics for rare neurological diseases. The company is engaged in the research, development, and commercialization of novel treatments for rare diseases mainly CNS disorders including Wakix for Narcolepsy.
Who are the top competitors of Harmony Biosciences?
Harmony Biosciences's top competitors include QurAlis, MindMed and Passage Bio.
What products or services does Harmony Biosciences offer?
Harmony Biosciences offers ZYN002.
Is Harmony Biosciences publicly traded?
Yes, Harmony Biosciences is publicly traded on NASDAQ under the ticker symbol HRMY.
How many acquisitions has Harmony Biosciences made?
Harmony Biosciences has made 1 acquisition, including Zynerba Pharma.
Who are Harmony Biosciences's investors?
Harmony Biosciences has 10 investors. Key investors include Fidelity Investments, Orbimed, HBM Healthcare Investments, CRG, and Aisling Capital.
What is Harmony Biosciences's ticker symbol?
The ticker symbol of Harmony Biosciences is HRMY on NASDAQ.